昇輝科技(300423.SZ):控股股東、實際控制人擬發生變更
格隆匯6月12日丨昇輝科技(300423.SZ)公佈,股東微紅投資2023年6月11日與寧波寧聚資產管理中心(有限合夥)作為基金管理人的融通1號證券投資基金(簡稱“寧聚資產”)簽訂《股份轉讓協議》,擬通過協議轉讓方式將其持有的公司5.05%股份無限售流通股份以每股8.34元的價格轉讓給寧聚資產。
公司已於2023年4月22日披露《昇輝科技:關於公司控股股東、實際控制人減持股份預披露的公吿》,紀法清基於自身資金需求計劃通過深圳證券交易所交易系統減持不超過公司股份3%股份。如實施完畢上述減持計劃及協議轉讓後公司控股股東及實際控制人將變更為公司目前第一大股東、公司董事長李昭強。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.